PURPOSE: In order to assess the determinants of non-compliance with a lipid-lowering therapy, a prospective study of the hyperlipidemic Korean subjects was carried out. METHODS: A total of 1019 patients was observed by 46 family physicians for the period of 1 year from January 1999 to January 2000. To ascertain the compliance associated with a lipid lowering drug (Simvastatin), we regularly followed up the hyperlipidemic patients at intervals of 4, 12 and 24 weeks. The criterion for evaluating compliance is to measure clinic attendance. Using a structured questionnaire, patients and physicians were asked about risk factors for the compliance. RESULTS: During the first 24 weeks of treatment, the lipid-lowering medication was continued by 52.3% and discontinued by 19.7%. The remaining 28% dropped out. Patient-related factors for non-compliance were young age, current smoker, lack of low fat diet and exercise, new user, no concomitant medication, and occurrence of adverse reactions. Physician-related factors for non-compliance were low patients' satisfaction with the physician, small number of hyperlipidemic patients per month and working in a relatively small hospital. CONCLUSIONS: Compliance with the lipid-lowering therapy was relatively low and several factors for non-compliance were detected.
PURPOSE: In order to assess the determinants of non-compliance with a lipid-lowering therapy, a prospective study of the hyperlipidemic Korean subjects was carried out. METHODS: A total of 1019 patients was observed by 46 family physicians for the period of 1 year from January 1999 to January 2000. To ascertain the compliance associated with a lipid lowering drug (Simvastatin), we regularly followed up the hyperlipidemic patients at intervals of 4, 12 and 24 weeks. The criterion for evaluating compliance is to measure clinic attendance. Using a structured questionnaire, patients and physicians were asked about risk factors for the compliance. RESULTS: During the first 24 weeks of treatment, the lipid-lowering medication was continued by 52.3% and discontinued by 19.7%. The remaining 28% dropped out. Patient-related factors for non-compliance were young age, current smoker, lack of low fat diet and exercise, new user, no concomitant medication, and occurrence of adverse reactions. Physician-related factors for non-compliance were low patients' satisfaction with the physician, small number of hyperlipidemic patients per month and working in a relatively small hospital. CONCLUSIONS: Compliance with the lipid-lowering therapy was relatively low and several factors for non-compliance were detected.
Authors: Steven A Blackwell; David K Baugh; Melissa A Montgomery; Gary M Ciborowski; Charles J Waldron; Gerald F Riley Journal: Medicare Medicaid Res Rev Date: 2011-12-14
Authors: Ataur R Khan; Zaki N Al-Abdul Lateef; Mohammad A Al Aithan; Montaser A Bu-Khamseen; Ibrahim Al Ibrahim; Shabbir A Khan Journal: J Family Community Med Date: 2012-01
Authors: Hye Young Kim; Jung Ah Lee; Young Sik Kim; Sung Sunwoo; Han Jin Oh; Chang Sup Kim; Keunsang Yum; Changjin Choi; Yoo Seock Jeong; Sang-Wook Song; Dae Hyun Kim; Young Sung Kim Journal: Korean J Fam Med Date: 2012-09-27
Authors: Hyun Ok Kim; Jung Ah Lee; Hee Won Suh; Young Sik Kim; Bum Soo Kim; Eun Sook Ahn; Young Jun Roh; Seong Gil Jung; Jin Mok Kim; Moon Kuk Kang; In Soon Ahn; Young Gyu Park Journal: Korean J Fam Med Date: 2013-09-26